Coagulation factor XIII B/F13B , Human, 重组蛋白 (His),Coagulation factor XIII B/F13B Protein, Human, Recombinant (His)

Coagulation factor XIII B/F13B , Human, 重组蛋白 (His)|TMPY-02185|TargetMol

价格	￥1890
包装	20μg

最小起订量	20μg
发货地	上海
更新日期	2026-05-08

QQ交谈微信洽谈

产品详情

中文名称:Coagulation factor XIII B/F13B , Human, 重组蛋白 (His)	英文名称:Coagulation factor XIII B/F13B Protein, Human, Recombinant (His)
品牌: TargetMol	产地: 美国
保存条件: Lyophilized powder: -20~-80°C for 1 year \| Solution: -80°C for 6 months	产品类别: 抑制剂
种属: Human	表达系统: HEK293 Cells
蛋白长度: A DNA sequence encoding the human F13B (P05160) (Met 1-Thr 661) was expressed, fused with a polyhistidine tag at the C-terminus. Predicted N terminal: Glu 21	标签: C-His
货号: T011\|TMPY-02185

Product Introduction

Bioactivity

名称	Coagulation factor XIII B/F13B Protein, Human, Recombinant (His)
描述	Coagulation factor XIII B chain, also known as Fibrin-stabilizing factor B subunit, Protein-glutamine gamma-glutamyltransferase B chain, Transglutaminase B chain and F13B, is a secreted protein which contains 1 Sushi ( CCP / SCR ) domains. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. Factor XIII acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. Defects in F13B are the cause of factor XIII subunit B deficiency ( FA13BD ) which is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.
存储条件	Lyophilized powder: -20~-80°C for 1 year \| Solution: -80°C for 6 months

关键字： FXIIIB;coagulation factor XIII, B polypeptide;Coagulation factor XIII;Coagulation factor 13;TargetMol

公司简介

成立日期	2013-04-18 （14年）	注册资本	589.8595万人民币
员工人数	100-500人	年营业额	￥ 1亿以上
主营行业	天然产物,生物化工,化学试剂,生物技术服务	经营模式	贸易,工厂,试剂,定制,服务

TargetMol 中国（陶术生物）

VIP 1年

公司成立：14年
注册资本：589.8595万人民币
企业类型：股份有限公司(非上市、自然人投资或控股)
主营产品：活性分子、生化试剂、天然产物、重组蛋白、抗体相关、试剂盒、药物筛选化合物库、技术服务
公司地址：静安区江场三路238号8楼

进入店铺

询盘

店内推荐

抗体 Anti-CD8 Antibody-PE-BZY594 (UCHT4)|TMAA-00335PBZY594|TargetMol

￥768

化合物 C.I. Acid blue 25|T85935|TargetMol

询价

IL-6, Mouse, 重组蛋白

￥7880

Coagulation factor XIII B/F13B , Human, 重组蛋白 (His)|TMPY-02185|TargetMol相关厂家报价

产品名称	价格		公司名称	报价日期
Recombinant Human Coagulation Factor XIII B chain / F13B Protein (His tag)	￥1950	VIP4年	上海沪震实业有限公司	2026-06-18
Human Coagulation Factor IX ELISA KIT	￥2600.00	VIP11年	北京索莱宝科技有限公司	2026-06-17
重组Human B2M 蛋白, C-His	￥1788	VIP2年	普健生物（武汉）科技有限公司	2026-06-18

内容声明:
以上所展示的信息由商家自行提供，内容的真实性、准确性和合法性由发布商家负责。商家发布价格指该商品的参考价格，并非原价，该价格可能随着市场变化，或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格，请咨询商家，以实际成交价格为准。请意识到互联网交易中的风险是客观存在的